our funding model

The END Fund was established as a new model, the first of its kind in the neglected tropical disease field: a philanthropic fund that increases resources, coordination, and collaboration toward the goal of ending neglected tropical diseases, thereby reducing the physical, social, economic, and systemic impact of these diseases for hundreds of millions of people. Our model is designed to mobilize resources to close the neglected tropical disease funding gap through partnerships with global philanthropists and private-sector investors. By pooling funds, the END Fund helps activist-philanthropists make outsized impacts with their investments. 

Through collaboration with our programmatic partners, we help deliver treatment at scale, accelerate innovations that improve the efficiency of drug delivery, provide program oversight to monitor quality and impact, and bring together partners, advocates, and investors. Because we direct resources and training activities through local partners, who know the landscape and can go where international agencies cannot or will not, we operate successfully and with measurable impact in some of the world’s most challenging environments due to war or  instability. Our focus has always been on large-scale change and we are committed to investing in and alongside local governments, building in-country technical tools and skills, and incorporating neglected tropical diseases into national health agendas for solid local ownership.

collaborative philanthropy

We help to unify a group of dedicated government, programmatic, pharmaceutical, and academic partners through a singular purpose: ending six neglected tropical diseases. Trachoma, intestinal worms, river blindness, lymphatic filariasis, schistosomiasis, and visceral leishmaniasis affect more than a billion people worldwide – about 1 in 5 people – creating economic ceilings by burdening them with painful, disabling conditions. 

The END Fund acts as a collaborator, bringing together resources, expertise, and strategic partnerships to address these diseases with the urgency they deserve. We harness the power of collective action. We recognize that global health challenges are too vast, too complex, for any one organization to tackle alone. 

Collaborative philanthropy is one of the most significant means by which funders can amplify their impact, and lauded by Bridgespan for its ability to achieve significant impact for investors, monitor this impact effectively, and enable funding to local actors. The END fund is one of the original collaboratives, established in 2012 to accelerate progress to control and eliminate neglected tropical diseases.

The END Fund draws on a network of partners from all sectors to pool resources and insights, creating a force far stronger than the sum of its parts. Over the last decade, the END Fund and its partners have provided nearly 2 billion treatments, working with communities and paving the way toward eliminating neglected tropical diseases.

We have proven that real change happens when people and organizations with shared values come together to address the world’s most overlooked health issues. And it does this while keeping its eyes firmly on the goal: a world free from preventable, neglected tropical diseases.